https://www.prweb.com/releases/nuview_life_sciences_liquid_biopsy_tech_changing_the_cancer_diagnosis_industry/prweb13880090.htm
Park City, UT (PRWEB) November 28, 2016 -- Medical researchers have discovered and exploited genetic mutations that are expressed only in precancerous or...
life sciencesliquid biopsycancer diagnosistechchanging
https://www.statnews.com/2025/11/20/abbott-exact-sciences-acquisition-cancer-screening-liquid-biopsy/
Nov 20, 2025 - The deal, one of the biggest health care acquisitions this year, includes Exact's blood-based and stool-based cancer tests.
exact sciencesabbottbuycancerdiagnostic
https://pulse2.com/abbott-exact-sciences/
Nov 21, 2025 - Abbott has agreed to acquire Exact Sciences in a deal valued at approximately $21 billion, marking one of the most significant diagnostics acquisitions in...
exact sciencesabbottbillionacquisitionexpand
https://www.technologynetworks.com/diagnostics/news/epic-sciences-awarded-a-phase-ii-sbir-contract-from-ncinih-to-develop-a-lung-cancer-diagnostic-blood-test-193554
New way to detect cancer based on circulating tumor cells in the blood could improve clinical diagnosis and inform personalized treatments.
epic sciencesphase iiawardedsbircontract
https://www.pharmaceutical-technology.com/data-insights/xtx-301-gilead-sciences-endometrial-cancer-likelihood-of-approval/
XTX-301 is under clinical development by Gilead Sciences and currently in Phase II for Endometrial Cancer.
gilead sciencesendometrial cancerxtxlikelihood
https://www.biospace.com/press-releases/accustem-sciences-to-offer-its-msc-blood-test-to-lung-cancer-screening-programs-in-the-united-states
blood testsciencesoffermsclung
https://www.gilead.com/science/therapeutic-areas/oncology
We’re innovating with next-generation therapies, combinations and technologies to expand our oncology portfolio and bring more life to people with cancer.
gilead sciencesnew hopeoncologypeoplecancer
https://www.bioworld.com/articles/726221-abbott-makes-cancer-screening-play-with-21b-exact-sciences-buy?v=preview
Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The deal will pay Exact Sciences...
cancer screeningexact sciencesabbottmakesplay
https://www.finanznachrichten.de/nachrichten-2024-09/63296150-gilead-sciences-working-to-build-next-generation-cancer-therapies-200.htm
NORTHAMPTON, MA / ACCESSWIRE / September 18, 2024 / Gilead SciencesJackson Egen learned the value of basic lab research as a graduate student at UC Berkeley in...
gilead sciencesnext generationworkingbuildcancer
https://www.birmingham.ac.uk/staff/profiles/cancer-genomic/rashid-mamunur
Dr Mamunur Rashid, Assistant Professor, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham
mamunur rashidgenomic sciencesdrdepartmentcancer
https://www.cancer.fr/professionnels-de-la-recherche/nos-actions-de-recherche/recherche-fondamentale
Grâce au développement de nouvelles technologies, notamment moléculaires, et à l'évolution des...
la recherchesoutienbiologieetsciences
https://www.pharmaceutical-technology.com/data-insights/xtx-301-gilead-sciences-non-small-cell-lung-cancer-likelihood-of-approval/
XTX-301 is under clinical development by Gilead Sciences and currently in Phase II for Non-Small Cell Lung Cancer.
gilead sciencessmall cellxtxnonlung
https://www.pharmaceutical-technology.com/data-insights/nelitolimod-sodium-trisalus-life-sciences-bile-duct-cancer-cholangiocarcinoma-likelihood-of-approval/
Nelitolimod sodium is under clinical development by TriSalus Life Sciences and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma).
bile duct cancerlife sciencessodium
https://www.pharmaceutical-technology.com/data-insights/ct-023-shenzhen-xiankangda-life-sciences-endometrial-cancer-likelihood-of-approval/
CT-023 is under clinical development by Shenzhen Xiankangda Life Sciences and currently in Phase I for Endometrial Cancer.
life sciencesendometrial cancerctshenzhen
https://www.biospace.com/caris-life-sciences-announces-huntsman-cancer-institute-joins-its-precision-oncology-alliance
Through its collaborative network focused on expanding the application of precision medicine in oncology, Caris will support Huntsman Cancer Institute's work...
huntsman cancer institutelife sciencescarisannouncesjoins
https://le.ac.uk/ggb/study/research-degrees/phd-projects/bayliss
Browse the PhD projects offered for supervision by Dr Chris Bayliss in the Department of Genetics and Genome Biology at the University of Leicester.
drchrisbaylissprojectsdepartment